Clinical Trial Update: Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a Venetoclax-containing therapy with microtransplant for newly diagnosed acute myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venclexta (venetoclax)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING